Personal information

Other IDs

ResearcherID: D-6269-2017

Activities

Collapse all

Works (50 of 129)

Items per page:
Page 1 of 3

Three-to-six-year-olds’ sexuality-related knowledge in Finland: impact of early education professionals’ training

Sex Education
2025-03-05 | Journal article
DOI: 10.1080/14681811.2025.2469914
Contributors: Raisa Cacciatore; Julia Kontio; Lotta Öhrmark; Dan Apter; Susanne Ingman-Friberg; Markus Jokela; Nina Sajaniemi; Julia Korkman; Riittakerttu Kaltiala
Source: check_circle
Crossref

An alternative term to make comprehensive sexuality education more acceptable in childhood

South African Journal of Childhood Education
2020-09-09 | Journal article
DOI: 10.4102/sajce.v10i1.857
Contributors: Raisa Cacciatore; Susanne Ingman-Friberg; Dan Apter; Nina Sajaniemi; Riittakerttu Kaltiala
Source: check_circle
Crossref

Contraception options: Aspects unique to adolescent and young adult

Best Practice & Research Clinical Obstetrics & Gynaecology
2018-04 | Journal article
DOI: 10.1016/j.bpobgyn.2017.09.010
Contributors: Dan Apter
Source: check_circle
Crossref

Evaluation of holistic sexuality education: A European expert group consensus agreement.

2016 | Journal article
DOI: 10.3109/13625187.2015.1050715
PMID: 26024010
Contributors: Ketting E; Friele M; Michielsen K; European Expert Group on Sexuality Education
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases.

2016 | Journal article
DOI: 10.1586/14760584.2016.1124763
PMID: 26902666
Contributors: Skinner SR; Apter D; De Carvalho N; Harper DM; Konno R; Paavonen J; Romanowski B; Roteli-Martins C; Burlet N; Mihalyi A et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial.

2016-12 | Journal article
DOI: 10.1080/21645515.2016.1183847
PMID: 27841725
PMC: PMC5215585
Contributors: Lehtinen M; Eriksson T; Apter D; Hokkanen M; Natunen K; Paavonen J; Pukkala E; Angelo MG; Zima J; David MP et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Targeting factors for change: contraceptive counselling and care of female adolescents.

2016-12 | Journal article
PMID: 27701924
Contributors: Bitzer J; Abalos V; Apter D; Martin R; Black A; Global CARE (Contraception: Access; Resources; Education) Group
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use.

2016-11 | Journal article
DOI: 10.1016/j.ejogrb.2016.11.022
PMID: 27930941
Contributors: Gemzell-Danielsson K; Apter D; Dermout S; Faustmann T; Rosen K; Schmelter T; Merz M; Nelson A
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial.

2016-11 | Journal article
DOI: 10.1016/j.ebiom.2016.10.036
PMID: 27810310
PMC: PMC5264483
Contributors: Stenman LK; Lehtinen MJ; Meland N; Christensen JE; Yeung N; Saarinen MT; Courtney M; Burcelin R; Lähdeaho ML; Linros J et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).

2016-10 | Journal article
DOI: 10.1016/j.contraception.2016.04.015
PMID: 27153745
Contributors: Apter D; Zimmerman Y; Beekman L; Mawet M; Maillard C; Foidart JM; Coelingh Bennink HJ
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.

2016-08 | Journal article
DOI: 10.1002/ijc.30391
PMID: 27541373
Contributors: Garland SM; Paavonen J; Jaisamrarn U; Naud P; Salmerón J; Chow SN; Apter D; Castellsagué X; Teixeira JC; Skinner SR et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents.

2016-06 | Journal article
DOI: 10.1016/j.contraception.2016.02.004
PMID: 26872720
Contributors: Gemzell-Danielsson K; Buhling KJ; Dermout SM; Lukkari-Lax E; Montegriffo E; Apter D
Source: Self-asserted source
Dan Apter via Europe PubMed Central

A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system (LNG-IUS 8) with the etonogestrel subdermal implant.

2016-03 | Journal article
DOI: 10.1016/j.fertnstert.2016.02.036
PMID: 27016644
Contributors: Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Danielsson KG
Source: Self-asserted source
Dan Apter via Europe PubMed Central

The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial.

2015 | Journal article
DOI: 10.1371/journal.pone.0135309
PMID: 26378938
PMC: PMC4574776
Contributors: Gemzell-Danielsson K; Apter D; Hauck B; Schmelter T; Rybowski S; Rosen K; Nelson A
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.

2015-10 | Journal article
DOI: 10.1097/gco.0000000000000208
PMID: 26308204
Contributors: Lehtinen M; Apter D
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

2015-07 | Journal article
DOI: 10.1016/s1470-2045(15)00047-9
PMID: 26071347
PMC: PMC4498478
Contributors: Kreimer AR; Struyf F; Del Rosario-Raymundo MR; Hildesheim A; Skinner SR; Wacholder S; Garland SM; Herrero R; David MP; Wheeler CM et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.

2015-04 | Journal article
DOI: 10.1128/cvi.00591-14
PMID: 25651922
PMC: PMC4375348
Contributors: Apter D; Wheeler CM; Paavonen J; Castellsagué X; Garland SM; Skinner SR; Naud P; Salmerón J; Chow SN; Kitchener HC et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial.

2015-03 | Journal article
DOI: 10.1016/j.vaccine.2014.12.019
PMID: 25593103
Contributors: Lehtinen M; Apter D; Baussano I; Eriksson T; Natunen K; Paavonen J; Vänskä S; Bi D; David MP; Datta S et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine - a pilot study.

2014 | Journal article
DOI: 10.1186/1756-0500-7-445
PMID: 25011477
PMC: PMC4105789
Contributors: Namujju PB; Pajunen E; Simen-Kapeu A; Hedman L; Merikukka M; Surcel HM; Kirnbauer R; Apter D; Paavonen J; Hedman K et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.

2014-10 | Journal article
DOI: 10.1186/s12879-014-0551-y
PMID: 25927224
PMC: PMC4251672
Contributors: Castellsagué X; Paavonen J; Jaisamrarn U; Wheeler CM; Skinner SR; Lehtinen M; Naud P; Chow SN; Del Rosario-Raymundo MR; Teixeira JC et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.

2014-08 | Journal article
DOI: 10.1093/infdis/jiu139
PMID: 24610876
PMC: PMC4111909
Contributors: Castellsagué X; Naud P; Chow SN; Wheeler CM; Germar MJ; Lehtinen M; Paavonen J; Jaisamrarn U; Garland SM; Salmerón J et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Prevention of HPV disease burden.

2014-07 | Journal article
DOI: 10.2217/whe.14.35
PMID: 25259894
Contributors: Lehtinen M; Nieminen P; Apter D; Paavonen J
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies.

2014-06 | Journal article
DOI: 10.1016/j.fertnstert.2014.03.004
PMID: 24726226
Contributors: Apter D; Gemzell-Danielsson K; Hauck B; Rosen K; Zurth C
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Correction: Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study.

2013 | Journal article
PMC: PMC3878864
Contributors: Jaisamrarn U; Castellsagué X; Garland SM; Naud P; Palmroth J; Del Rosario-Raymundo MR; Wheeler CM; Salmerón J; Chow S; Apter D et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach.

2013 | Journal article
DOI: 10.1371/journal.pone.0072088
PMID: 24009669
PMC: PMC3756967
Contributors: Vänskä S; Auranen K; Leino T; Salo H; Nieminen P; Kilpi T; Tiihonen P; Apter D; Lehtinen M
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.

2013 | Journal article
DOI: 10.1371/journal.pone.0079260
PMID: 24260180
PMC: PMC3834039
Contributors: Jaisamrarn U; Castellsagué X; Garland SM; Naud P; Palmroth J; Del Rosario-Raymundo MR; Wheeler CM; Salmerón J; Chow SN; Apter D et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial.

2013-12 | Journal article
DOI: 10.1097/aog.0000000000000019
PMID: 24240244
Contributors: Nelson A; Apter D; Hauck B; Schmelter T; Rybowski S; Rosen K; Gemzell-Danielsson K
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.

2013-11 | Journal article
DOI: 10.1093/infdis/jit360
PMID: 24092907
PMC: PMC3789574
Contributors: Szarewski A; Skinner SR; Garland SM; Romanowski B; Schwarz TF; Apter D; Chow SN; Paavonen J; Del Rosario-Raymundo MR; Teixeira JC et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Impact of HPV16/18 vaccination on quality of life: a pilot study.

2013-10 | Journal article
DOI: 10.3109/13625187.2013.801953
PMID: 23768267
Contributors: Eriksson T; Torvinen S; Woodhall SC; Lehtinen M; Apter D; Harjula K; Hokkanen M; Rissanen P; Paavonen J; Lehtinen M
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Conscientious objection and induced abortion in Europe.

2013-08 | Journal article
DOI: 10.3109/13625187.2013.819848
PMID: 23848269
Contributors: Heino A; Gissler M; Apter D; Fiala C
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up.

2013-06 | Journal article
DOI: 10.1002/ijc.27971
PMID: 23180157
Contributors: Rana MM; Huhtala H; Apter D; Eriksson T; Luostarinen T; Natunen K; Paavonen J; Pukkala E; Lehtinen M
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Adolescent contraception.

2012 | Journal article
DOI: 10.1159/000326704
PMID: 22846536
Contributors: Apter D
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Sexuality education: Finnish and Chilean experiences.

2012 | Journal article
DOI: 10.1159/000331669
PMID: 22846538
Contributors: Apter D; Molina Cartes R
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination.

2012-12 | Journal article
DOI: 10.1002/ijc.27586
PMID: 22492244
Contributors: Palmroth J; Merikukka M; Paavonen J; Apter D; Eriksson T; Natunen K; Dubin G; Lehtinen M
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.

2012-12 | Journal article
DOI: 10.1016/j.ygyno.2012.08.033
PMID: 22940493
Contributors: Roset Bahmanyar E; Paavonen J; Naud P; Salmerón J; Chow SN; Apter D; Kitchener H; Castellsagué X; Teixeira JC; Skinner SR et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18.

2012-07 | Journal article
DOI: 10.1002/ijc.26362
PMID: 21858807
Contributors: Szarewski A; Poppe WA; Skinner SR; Wheeler CM; Paavonen J; Naud P; Salmeron J; Chow SN; Apter D; Kitchener H et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.

2012-03 | Journal article
DOI: 10.1016/j.fertnstert.2011.12.003
PMID: 22222193
Contributors: Gemzell-Danielsson K; Schellschmidt I; Apter D
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

2012-01 | Journal article
DOI: 10.1016/s1470-2045(11)70287-x
PMID: 22075170
Contributors: Wheeler CM; Castellsagué X; Garland SM; Szarewski A; Paavonen J; Naud P; Salmerón J; Chow SN; Apter D; Kitchener H et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

2012-01 | Journal article
DOI: 10.1016/s1470-2045(11)70286-8
PMID: 22075171
Contributors: Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

[Unprotected sex].

2011 | Journal article
PMID: 21834337
Contributors: Hiltunen-Back E; Apter D
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Impact of HPV vaccination on young women's quality of life - a five year follow-up study.

2011-02 | Journal article
DOI: 10.3109/13625187.2010.536921
PMID: 21158521
Contributors: Woodhall S; Eriksson T; Nykänen AM; Huhtala H; Rissanen P; Apter D; Paavonen J; Lehtinen M
Source: Self-asserted source
Dan Apter via Europe PubMed Central

[Multiple challenges of teenage pregnancy and maternity].

2010 | Journal article
PMID: 20597334
Contributors: Halonen M; Apter D
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Aspects of sexuality education in Europe - definitions, differences and developments.

2010-06 | Journal article
DOI: 10.3109/13625181003797280
PMID: 20465399
Contributors: Loeber O; Reuter S; Apter D; van der Doef S; Lazdane G; Pinter B
Source: Self-asserted source
Dan Apter via Europe PubMed Central

[HPV and effectiveness of chlamydia control].

2009 | Journal article
PMID: 19678493
Contributors: Lehtinen M; Eriksson T; Apter D
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.

2009-12 | Journal article
DOI: 10.1016/j.contraception.2009.05.128
PMID: 19913143
Contributors: Teichmann A; Apter D; Emerich J; Greven K; Klasa-Mazurkiewicz D; Melis GB; Spaczynski M; Grubb GS; Constantine GD; Spielmann D
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

2009-07 | Journal article
DOI: 10.1016/s0140-6736(09)61248-4
PMID: 19586656
Contributors: Paavonen J; Naud P; Salmerón J; Wheeler CM; Chow SN; Apter D; Kitchener H; Castellsague X; Teixeira JC; Skinner SR et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Male hormonal contraception: a double-blind, placebo-controlled study.

2008-07 | Journal article
DOI: 10.1210/jc.2008-0265
PMID: 18413423
Contributors: Mommers E; Kersemaekers WM; Elliesen J; Kepers M; Apter D; Behre HM; Beynon J; Bouloux PM; Costantino A; Gerbershagen HP et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

2007-06 | Journal article
DOI: 10.1016/s0140-6736(07)60946-5
PMID: 17602732
Contributors: Paavonen J; Jenkins D; Bosch FX; Naud P; Salmerón J; Wheeler CM; Chow SN; Apter DL; Kitchener HC; Castellsague X et al.
Source: Self-asserted source
Dan Apter via Europe PubMed Central

[Not Available].

2006 | Journal article
PMID: 17091633
Contributors: Kosunen E; Ala-Fossi N; Ala-Fossi SL; Apter D; Komulainen J; Peura S; Savolainen T; Virtala A
Source: Self-asserted source
Dan Apter via Europe PubMed Central

Preventing common sexually transmitted infections in adolescents: time for rethinking.

2006-12 | Journal article
DOI: 10.1080/13625180601140237
PMID: 17484188
Contributors: Lehtinen M; Paavonen J; Apter D
Source: Self-asserted source
Dan Apter via Europe PubMed Central
Items per page:
Page 1 of 3

Peer review (1 review for 1 publication/grant)

Review activity for Journal of adolescent health (1)
How many people are using ORCID?